semaglutide and pancreatitis on Ozempic (semaglutide 0.5-2 mg): Week-by-Week Timeline of What to Expect Reconciling GLP-1s and Pancreatitis

The questionnaire is detailed enough to give providers the information they need for prescribing decisions, covering areas like cardiovascular health, thyroid function, diabetes status, and family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome, both of which are contraindications for GLP-1 medications

392 :e086886 doi:10.1136/bmj-2025-086886 Vlker KM, Prechtl BLH, Bormann NL, Choi DS

Furthermore, the combination of these two medications in T2D diabetic mice with NASH suppressed PIO-induced fluid retention through IPRA-induced osmotic diuresis [114]

It is possible that a future study will show something different, but if a proper test group is studied like we did, and if a large number of potential patients is studied, like we did, then I expect that additional studies of this topic will demonstrate similar results